HUTCHMED (China) Ltd 2023 Annual Report with Sustainability Disclosures
Company: HUTCHMED (China) Ltd
Sector: Manufacturing
Country: Hong Kong
Year: 2023
Type: Annual Report with Sustainability Disclosures
Pages: 416
The report highlights a landmark 2023, with revenue increasing 97% to $838.0 million and net income attributable to HUTCHMED reaching $100.8 million. It also records major commercial milestones, including U.S. approval and launch of Fruzaqla and the Takeda fruquintinib partnership, which generated substantial upfront and milestone payments. Sustainability governance remained Board-led, supported by a Sustainability Committee, while the company refreshed its materiality topics and began screening and measuring material Scope 3 categories. The report also notes implementation of a digital data collection platform to improve sustainability data reliability, comparability, and transparency.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.